Aside from this being frustratingly uncivil I would suggest it is, from a practical standpoint, incorrect. E.g. in the argument over GERN recently blade was assumed to be completely incorrect on the interpretation of the abstract - but ended up being more correct than many of us gave him credit for. And financially very correct.
Blade, and one or two others, come from a different perspective than the science/math type of bent prevalent on this boards. A more social networking, company body language style of investing - but without the "rah, rah" naivete that is sooo common in biotech (especially in those without the science/math grounding). I personally find them *more* useful than 'just another science perspective' - precisely because their viewpoint is different while still avoiding the rah, rah dangers of biotech.